Affiliate of JLL Partners Commences Tender Offer for BioClinica at $7.25/Share

BioClinica®, Inc. (NASDAQ: BIOC ), a leading global provider of clinical trial management solutions and JLL Partners, Inc. (“JLL”), a leading private equity investment firm, announced today that BC Acquisition Corp. (“Purchaser”), which is a wholly-owned subsidiary of BioCore Holdings, Inc. (“Parent”), each of which is an affiliate of JLL, has commenced a